Geographic variations of pre-exposure prophylaxis reversal and abandonment among United States counties.

Rahel Dawit, William C Goedel, Sean C Reid, Jalpa A Doshi, Amy S Nunn, Philip A Chan, Lorraine T Dean
Author Information
  1. Rahel Dawit: Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD.
  2. William C Goedel: Department of Epidemiology, Brown University, Providence, RI.
  3. Sean C Reid: Department of Geography, University of California, Santa Barbara, CA.
  4. Jalpa A Doshi: Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  5. Amy S Nunn: Department of Behavioral and Social Sciences, Brown University.
  6. Philip A Chan: Department of Medicine, Alpert Medical School of Brown University, Providence, RI, USA.
  7. Lorraine T Dean: Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD.

Abstract

OBJECTIVE: In the United States, one in five newly insurer-approved pre-exposure prophylaxis (PrEP) prescriptions are reversed with over 70% of those reversed, being abandoned. Given the Ending the HIV Epidemic (EHE) initiative's goals, we assessed geographic variations of PrEP reversal and abandonment across EHE and non-EHE counties in the United States.
DESIGN: This was a cross-sectional analysis of secondary data.
METHODS: Data were collected from Symphony Analytics for adults 18 years and older, with a newly prescribed PrEP claim. Using the proportion of PrEP prescriptions by county, hotspot analysis was conducted utilizing Getis Ord Gi��� statistics stratified by EHE and non EHE counties. Multivariable logistic regression was used to identify factors associated with residing in hotspots of PrEP reversal or PrEP abandonments.
RESULTS: Across 516 counties representing 36,204 patients, the overall PrEP reversal rate was 19.4%, whereas the PrEP abandonment rate was 13.7%. Reversals and abandonments were higher for non-EHE (22.7 and 17.1%) than EHE (15.6 and 10.5%) counties. In both EHE and non-EHE counties, younger age, less education, females, and an out-of-pocket cost of greater than $100, were significantly associated with greater likelihood of residing in hotspots of PrEP reversal or abandonment, while Hispanics, Medicaid recipients, and an out-of-pocket cost of $10 or less had lower likelihood of residing in hotspots of reversal and abandonment.
CONCLUSION: Findings indicate the need for implementation of focused interventions to address disparities observed in PrEP reversal and abandonment. Moreover, to improve primary PrEP adherence, national PrEP access programs should streamline and improve PrEP accessibility across different geographic jurisdictions.

References

  1. Prev Sci. 2017 Jul;18(5):505-516 [PMID: 28101813]
  2. AIDS Behav. 2016 Jul;20(7):1499-513 [PMID: 26891840]
  3. Ann Epidemiol. 2020 Apr;44:16-30 [PMID: 32088073]
  4. J Adolesc Health. 2022 Jan;70(1):28-41 [PMID: 34059426]
  5. J Int AIDS Soc. 2016 Jun 13;19(1):20903 [PMID: 27302837]
  6. AIDS Behav. 2018 Sep;22(9):3044-3056 [PMID: 29789985]
  7. JMIR Public Health Surveill. 2019 Feb 04;5(1):e12405 [PMID: 30714945]
  8. Ann Epidemiol. 2018 Dec;28(12):841-849 [PMID: 29983236]
  9. J Appl Meas. 2017;18(2):178-193 [PMID: 28961153]
  10. J Acquir Immune Defic Syndr. 2023 May 1;93(1):34-41 [PMID: 36626893]
  11. AIDS. 2021 Nov 15;35(14):2375-2381 [PMID: 34723852]
  12. Ann Epidemiol. 2020 Sep;49:1-7 [PMID: 32951802]
  13. Int J STD AIDS. 2022 Dec;33(14):1199-1205 [PMID: 36271632]
  14. J Law Med Ethics. 2022;50(S1):51-54 [PMID: 35902086]
  15. Ann Epidemiol. 2018 Dec;28(12):833-840 [PMID: 30037634]
  16. Ann Epidemiol. 2020 May;45:24-31.e3 [PMID: 32336655]
  17. AIDS Behav. 2021 Nov;25(Suppl 2):155-164 [PMID: 33818642]
  18. JAMA. 2019 Mar 5;321(9):844-845 [PMID: 30730529]
  19. MMWR Morb Mortal Wkly Rep. 2021 Oct 08;70(40):1395-1400 [PMID: 34618795]
  20. Ann Epidemiol. 2018 Dec;28(12):858-864 [PMID: 30406756]
  21. AIDS Behav. 2023 Aug;27(8):2606-2616 [PMID: 36670210]
  22. Am J Public Health. 2019 Sep;109(9):1216-1223 [PMID: 31318587]
  23. PLoS One. 2017 Sep 27;12(9):e0184014 [PMID: 28953905]
  24. J Law Med Ethics. 2022;50(S1):8-23 [PMID: 35902089]

Grants

  1. T32 AI102623/NIAID NIH HHS
  2. R01 NR017573/NINR NIH HHS
  3. R21 NR018387/NINR NIH HHS
  4. P30 AI094189/NIAID NIH HHS
  5. R25 MH083620/NIMH NIH HHS

MeSH Term

Adult
Female
Humans
United States
Pre-Exposure Prophylaxis
HIV Infections
Cross-Sectional Studies
Medicaid
Prescriptions
Anti-HIV Agents

Chemicals

Anti-HIV Agents

Word Cloud

Created with Highcharts 10.0.0PrEPreversalEHEabandonmentcountiesUnitedStatesnon-EHEresidinghotspotsnewlypre-exposureprophylaxisprescriptionsreversedgeographicvariationsacrossanalysisassociatedabandonmentsratelessout-of-pocketcostgreaterlikelihoodimproveOBJECTIVE:onefiveinsurer-approved70%abandonedGivenEndingHIVEpidemicinitiative'sgoalsassessedDESIGN:cross-sectionalsecondarydataMETHODS:DatacollectedSymphonyAnalyticsadults18yearsolderprescribedclaimUsingproportioncountyhotspotconductedutilizingGetisOrdGi���statisticsstratifiednonMultivariablelogisticregressionusedidentifyfactorsRESULTS:Across516representing36204patientsoverall194%whereas137%Reversalshigher227171%156105%youngerageeducationfemales$100significantlyHispanicsMedicaidrecipients$10lowerCONCLUSION:FindingsindicateneedimplementationfocusedinterventionsaddressdisparitiesobservedMoreoverprimaryadherencenationalaccessprogramsstreamlineaccessibilitydifferentjurisdictionsGeographicamong

Similar Articles

Cited By

No available data.